The National Heart, Lung, and Blood Institute (NHLBI) COPD National Action Plan; Request for Public Comments, 66666-66667 [2016-23392]
Download as PDF
<![CDATA[
66666
Federal Register / Vol. 81, No. 188 / Wednesday, September 28, 2016 / Notices
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 BTRC review
(2017/01).
Date: November 17, 2016.
Time: 08:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Bethesda, MD 20892, (301)
451–4794, dennis.hlasta@nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; R13 Review (2017/
01).
Date: December 6, 2016.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959, Bethesda, MD
20892, (301) 451–3397, sukharem@
mail.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Ancillary
Studies.
Date: November 17, 2016.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Elena Sanovich, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7351, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–8886,
sanoviche@mail.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Improving Diabetes
Management in Children with Type 1
Diabetes (DP3).
Date: November 17, 2016.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Digestive Diseases
Centers.
Date: November 17–18, 2016.
Time: 6:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel,
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, Room 7017, 6707
Democracy Boulevard, Bethesda, MD 20892,
(301) 594–7637, davila-bloomm@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Dated: September 21, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–23313 Filed 9–27–16; 8:45 am]
BILLING CODE 4140–01–P
mstockstill on DSK3G9T082PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
18:04 Sep 27, 2016
Jkt 238001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 22, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–23315 Filed 9–27–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
The National Heart, Lung, and Blood
Institute (NHLBI) COPD National Action
Plan; Request for Public Comments
NHLBI, with input from
federal and nonfederal partners, is
developing the COPD National Action
Plan to help guide stakeholders
nationwide in their efforts to reduce the
burden of Chronic Obstructive
Pulmonary Disease (COPD). The
purpose of this notice is to seek public
input on the current draft of the COPD
National Action Plan.
DATES: To ensure consideration, your
responses must be received by Friday,
October 28, 2016.
ADDRESSES: Responses to this Notice
must be submitted electronically using
either the web-based format at https://
www.nhlbi.nih.gov/health/educational/
copd/get-involved/town-hall.htm or
email to COPDActionPlan@
porternovelli.com.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Lenora E. Johnson, DrPH; Director,
Office of Science Policy, Engagement,
Education, and Communications;
National Heart, Lung, and Blood
Institute; 9000 Rockville Pike, Bldg. 31,
MSC 2480, Bethesda, MD 20892–2480,
Telephone: 301–496–4236, Fax: 301–
402–2405.
SUPPLEMENTARY INFORMATION:
Background
The NHLBI—part of the National
Institutes of Health (NIH)—plans,
conducts, and supports research related
to the causes, prevention, diagnosis, and
treatment of heart, blood vessel, lung,
and blood diseases; and sleep disorders.
The NHLBI is the NIH institute with
primary responsibility for portfolio of
research related to lung diseases.
The NHLBI provides global leadership
for research, training, and education
programs to promote the prevention and
treatment of heart, lung, and blood
diseases and enhance the health of all
individuals so that they can live longer
and more fulfilling lives. The Institute
E:\FR\FM\28SEN1.SGM
28SEN1
Federal Register / Vol. 81, No. 188 / Wednesday, September 28, 2016 / Notices
also administers national health
education campaigns on COPD, women
and heart disease, healthy weight for
children, and other topics. NHLBI press
releases and other materials are
available online at www.nhlbi.nih.gov.
The importance of COPD as a public
health issue was highlighted by the
Senate Appropriations Committee in
fiscal year 2012 with its charge to the
NHLBI ‘‘to work with community
stakeholders and other federal agencies,
including the Centers for Disease
Control and Prevention (CDC), to
develop a national action plan to
respond to the growing burden of this
disease.’’ A letter from Reps. John
Lewis, Dave Joyce and Carol Shea-Porter
in November 2014 to Dr. Thomas
Frieden, Director of the CDC, and Dr.
Francis Collins, Director of the NIH,
requested ‘‘that the NIH and the CDC
create a National Action Plan for COPD
in fiscal year 2015.’’
In response to these requests and in
collaboration with CDC and other
federal partners, the NHLBI organized
several trans-governmental preparatory
workshops to discuss the development
of such a plan. These workshops
informed the establishment of six initial
core goals to be addressed by the COPD
National Action Plan.
In early 2016, the NHLBI hosted a
COPD Town Hall Meeting with both
federal and nonfederal stakeholders,
including patients and their families.
During the two-day meeting, attendees
were invited to join one of six working
groups, each charged with developing
objectives, strategies, and benchmarks
for a specified goal. The
recommendations made by the working
groups directly informed the
development of the full draft of the
COPD National Action Plan that is now
available for public input.
Following the public comment
period, the NHLBI will incorporate the
feedback, finalize the COPD National
Action Plan, and post the document for
the public via the NHLBI Web site.
mstockstill on DSK3G9T082PROD with NOTICES
Information Requested
This notice invites public comment
on the draft COPD National Action Plan
draft. We ask that the public review the
draft and provide feedback on its
content, strategies, and tactics, as well
as the opportunities it suggests
organizations consider to help reduce
the burden of COPD.
Input is being sought on each of the
areas identified below, and respondents
can provide comment to select areas or
all of them.
(1) Goal 1: Empower people with
COPD, their families, and caregivers to
VerDate Sep<11>2014
18:04 Sep 27, 2016
Jkt 238001
recognize and reduce the burden of
COPD.
(2) Goal 2: Improve the prevention,
diagnosis, treatment, and management
of COPD by promoting and sustaining
the education and training of health care
professionals.
(3) Goal 3: Collect, analyze,
disseminate, and report COPD-related
public health data that drives change
and tracks progress.
(4) Goal 4: Increase and sustain
research to better understand
prevention, pathogenesis, diagnosis,
treatment, and management of COPD.
(5) Goal 5: Translate national policy,
education, and program
recommendations into legislative,
research, and public health care actions.
(6) Additional comments,
information, or suggestions about
organizations that should be part of the
COPD National Action Plan
implementation.
General Information
All of the fields in the response are
optional and voluntary. Any personal
identifiers will be removed when
responses are compiled. Proprietary,
classified, confidential, or sensitive
information should not be included in
your response. This notice is for
planning purposes only and is not a
solicitation for applications or an
obligation on the part of the United
States (U.S.) government to provide
support for any ideas identified in
response to it. Please note that the U.S.
government will not pay for the
preparation of any comment submitted
or for its use of that comment.
Please provide your name and email
address so that we can follow up with
you should we have any questions
regarding your submission. If you are a
member of a particular advocacy or
professional organization, please
indicate the name and primary focus of
the organization (i.e., research support,
patient care, etc.) and whether you are
responding on behalf of your
organization. If you are not, please
indicate your position within the
organization.
Privacy Act Notification Statement:
We are requesting your comments on
the draft COPD National Action Plan.
The information you provide may be
disclosed to NHLBI staff and contractors
working on our behalf. Submission of
this information is voluntary. However,
the information you provide will help
us develop a more complete COPD
National Action Plan. Additionally,
contact details will allow us to follow
up with you should there be any
questions to your feedback.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
66667
Collection of this information is
authorized under 42 U.S.C. 203, 24 1,
2891–1 and 44 U.S.C. 310 I and Section
30 l and 493 of the Public Health
Service Act regarding the establishment
of the National Institutes of Health, its
general authority to conduct and fund
research and to provide training
assistance, and its general authority to
maintain records in connection with
these and its other functions.
Dated: September 21, 2016.
Gary H. Gibbons,
Director, National Heart, Lung, and Blood
Institute, National Institutes of Health.
[FR Doc. 2016–23392 Filed 9–27–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; R21 Innovation Awards.
Date: October 24, 2016.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Democracy Boulevard, Room 1037, Bethesda,
MD 20892.
Contact Person: Christine A. Livingston,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Center for
Advancing Translational Sciences (NCATS),
National Institutes of Health, 6701
Democracy Blvd., Democracy 1, Room 1073,
Bethesda, MD 20892, (301) 435–1348,
livingsc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
E:\FR\FM\28SEN1.SGM
28SEN1
]]>Agencies
[Federal Register Volume 81, Number 188 (Wednesday, September 28, 2016)]
[Notices]
[Pages 66666-66667]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23392]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
The National Heart, Lung, and Blood Institute (NHLBI) COPD
National Action Plan; Request for Public Comments
SUMMARY: NHLBI, with input from federal and nonfederal partners, is
developing the COPD National Action Plan to help guide stakeholders
nationwide in their efforts to reduce the burden of Chronic Obstructive
Pulmonary Disease (COPD). The purpose of this notice is to seek public
input on the current draft of the COPD National Action Plan.
DATES: To ensure consideration, your responses must be received by
Friday, October 28, 2016.
ADDRESSES: Responses to this Notice must be submitted electronically
using either the web-based format at https://www.nhlbi.nih.gov/health/educational/copd/get-involved/town-hall.htm or email to
COPDActionPlan@porternovelli.com.
FOR FURTHER INFORMATION CONTACT: Lenora E. Johnson, DrPH; Director,
Office of Science Policy, Engagement, Education, and Communications;
National Heart, Lung, and Blood Institute; 9000 Rockville Pike, Bldg.
31, MSC 2480, Bethesda, MD 20892-2480, Telephone: 301-496-4236, Fax:
301-402-2405.
SUPPLEMENTARY INFORMATION:
Background
The NHLBI--part of the National Institutes of Health (NIH)--plans,
conducts, and supports research related to the causes, prevention,
diagnosis, and treatment of heart, blood vessel, lung, and blood
diseases; and sleep disorders. The NHLBI is the NIH institute with
primary responsibility for portfolio of research related to lung
diseases.
The NHLBI provides global leadership for research, training, and
education programs to promote the prevention and treatment of heart,
lung, and blood diseases and enhance the health of all individuals so
that they can live longer and more fulfilling lives. The Institute
[[Page 66667]]
also administers national health education campaigns on COPD, women and
heart disease, healthy weight for children, and other topics. NHLBI
press releases and other materials are available online at
www.nhlbi.nih.gov.
The importance of COPD as a public health issue was highlighted by
the Senate Appropriations Committee in fiscal year 2012 with its charge
to the NHLBI ``to work with community stakeholders and other federal
agencies, including the Centers for Disease Control and Prevention
(CDC), to develop a national action plan to respond to the growing
burden of this disease.'' A letter from Reps. John Lewis, Dave Joyce
and Carol Shea-Porter in November 2014 to Dr. Thomas Frieden, Director
of the CDC, and Dr. Francis Collins, Director of the NIH, requested
``that the NIH and the CDC create a National Action Plan for COPD in
fiscal year 2015.''
In response to these requests and in collaboration with CDC and
other federal partners, the NHLBI organized several trans-governmental
preparatory workshops to discuss the development of such a plan. These
workshops informed the establishment of six initial core goals to be
addressed by the COPD National Action Plan.
In early 2016, the NHLBI hosted a COPD Town Hall Meeting with both
federal and nonfederal stakeholders, including patients and their
families. During the two-day meeting, attendees were invited to join
one of six working groups, each charged with developing objectives,
strategies, and benchmarks for a specified goal. The recommendations
made by the working groups directly informed the development of the
full draft of the COPD National Action Plan that is now available for
public input.
Following the public comment period, the NHLBI will incorporate the
feedback, finalize the COPD National Action Plan, and post the document
for the public via the NHLBI Web site.
Information Requested
This notice invites public comment on the draft COPD National
Action Plan draft. We ask that the public review the draft and provide
feedback on its content, strategies, and tactics, as well as the
opportunities it suggests organizations consider to help reduce the
burden of COPD.
Input is being sought on each of the areas identified below, and
respondents can provide comment to select areas or all of them.
(1) Goal 1: Empower people with COPD, their families, and
caregivers to recognize and reduce the burden of COPD.
(2) Goal 2: Improve the prevention, diagnosis, treatment, and
management of COPD by promoting and sustaining the education and
training of health care professionals.
(3) Goal 3: Collect, analyze, disseminate, and report COPD-related
public health data that drives change and tracks progress.
(4) Goal 4: Increase and sustain research to better understand
prevention, pathogenesis, diagnosis, treatment, and management of COPD.
(5) Goal 5: Translate national policy, education, and program
recommendations into legislative, research, and public health care
actions.
(6) Additional comments, information, or suggestions about
organizations that should be part of the COPD National Action Plan
implementation.
General Information
All of the fields in the response are optional and voluntary. Any
personal identifiers will be removed when responses are compiled.
Proprietary, classified, confidential, or sensitive information should
not be included in your response. This notice is for planning purposes
only and is not a solicitation for applications or an obligation on the
part of the United States (U.S.) government to provide support for any
ideas identified in response to it. Please note that the U.S.
government will not pay for the preparation of any comment submitted or
for its use of that comment.
Please provide your name and email address so that we can follow up
with you should we have any questions regarding your submission. If you
are a member of a particular advocacy or professional organization,
please indicate the name and primary focus of the organization (i.e.,
research support, patient care, etc.) and whether you are responding on
behalf of your organization. If you are not, please indicate your
position within the organization.
Privacy Act Notification Statement: We are requesting your comments
on the draft COPD National Action Plan. The information you provide may
be disclosed to NHLBI staff and contractors working on our behalf.
Submission of this information is voluntary. However, the information
you provide will help us develop a more complete COPD National Action
Plan. Additionally, contact details will allow us to follow up with you
should there be any questions to your feedback.
Collection of this information is authorized under 42 U.S.C. 203,
24 1, 2891-1 and 44 U.S.C. 310 I and Section 30 l and 493 of the Public
Health Service Act regarding the establishment of the National
Institutes of Health, its general authority to conduct and fund
research and to provide training assistance, and its general authority
to maintain records in connection with these and its other functions.
Dated: September 21, 2016.
Gary H. Gibbons,
Director, National Heart, Lung, and Blood Institute, National
Institutes of Health.
[FR Doc. 2016-23392 Filed 9-27-16; 8:45 am]
BILLING CODE 4140-01-P
